dr. chung on the rationale of the keynote-811 trial in her2 gastric cancer
Published 4 years ago • 182 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
1:48
dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
0:58
dr. chung on the importance of genomic testing in pancreatic cancer
-
3:52
her2-positive gastric cancer
-
0:31
copy of dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
1:17
dr. arkenau on the potential of immunotherapy in gastric cancer
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
3:12
advances in her2-targeted therapies for gastric cancer
-
2:00
dr. janjigian on pembrolizumab triplet in her2 esophagogastric cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
1:31
dr. gwin on the mechanism of action of 𝞪-tea in her2-positive metastatic breast cancer
-
0:54
dr. shah on the trastuzumab biosimilar in gastric cancer
-
0:58
dr. davis on the potential for maintenance therapy in gastric cancer
-
5:54
gastric cancer: global perspectives on maintenance therapy
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
1:24
dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
-
1:28
dr forsyth on leptomeningeal disease in her2 breast cancer and tnbc